Fritextsökning
Innehållstyper
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
New nano professor in Denmark
The Technical University of Denmark has appointed a recognized physicist as a new professor of miniaturized sensors.
-
USA influerar ny stiftelse
Nu startar den nya stiftelsen Forska Sverige som, likt sin amerikanska motsvarighet Research America, ska stärka den medicinska forskningen.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
Sverige behöver mer innovativ politik
Det krävs ett modigt ledarskap på alla nivåer, inom kommun, landsting och nationellt.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...
-
Think outside the... brain
Riitta Hari from the Brain Research Unit at the Helsinki University of Technology has recently stated that the mind is more than just the brain.
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
Fat cells' reaction differs with body weight
The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...
-
New CEO to Medivir
The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.
-
Astrazeneca i motvind
Astrazenecas patent för blockbustrarna Nexium och Seroquel går ut inom några år och det går trögt för de nya läkemedelshoppen.
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
How to get visitors to your booth
Food, ball throwing and laser engraved pens. There are many tricks to attract visitors to the stands at Scanlab.
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
Patienterna bör involveras tidigt
KRÖNIKA: "Konstaterandet att alla tjänar på att patienterna involveras i fler delar av processen känns rätt självklart, men det finns en del kvar att göra rent praktiskt."
-
Floppat diabetesvaccin visar positiv effekt
Nya forskningsresultat visar att Diamyd-vaccinets immunologiska effekt håller i sig fyra år efter behandling.
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
-
Ideon - Sveriges äldsta forskningspark
Gammal är inte synonymt med tråkig. Sveriges äldsta forskningspark Ideon lyckas fortfarande attrahera unga företag med stora idéer. Framgångsreceptet? Att forts...
-
Life science management for hire
Do you need help getting your biotech company off and running? Camoleon is a new type of consultant that offers help with business and innovation management and...
-
EU grants project on toxicity of nanomaterials
A multinational research project has have been awarded EUR 3 358 500 from the European Commission to study the hazardous effects of engineered nanomaterials on ...
-
Anything is measurable
At the seminar "Du är vad jag mäter - hjärnans kemi i ett provrör", Jonas Bergquist, professor of analytical chemistry and neurochemistry, will dig deep into th...
BREAKING